ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
13 hedge funds and large institutions have $179K invested in ENVUE MEDICAL INC NEW in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
322% more capital invested
Capital invested by funds: $42.5K → $179K (+$137K)
160% more funds holding
Funds holding: 5 → 13 (+8)
5.61% more ownership
Funds ownership: 1.69% → 7.3% (+5.6%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$48.5K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$29.3K |
| 3 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$21.6K |
| 4 |
Morgan Stanley
New York
|
+$21.6K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$21.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$38.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$78 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$18 |
| 4 |
Citigroup
New York
|
-$2 |
FEED Hedge Fund Activity: Q1 2026 in Review
13 of the 8,203 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q1 2026, worth a combined $179K — up 322% from $42.5K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new FEED positions and 2 closed out — a net gain of 8 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $48.5K. The largest seller was Citadel Advisors, exiting entirely with an estimated $38.2K sold.
- 13 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q1 2026, up from 5 in Q4 2025.
- Funds reported $179K of ENVUE MEDICAL INC NEW stock for Q1 2026, up 322% quarter-over-quarter.
- 10 funds opened new ENVUE MEDICAL INC NEW positions in Q1 2026 and 2 closed out, a net change of +8 holders.
- The largest ENVUE MEDICAL INC NEW buyer in Q1 2026 was Geode Capital Management, an estimated $48.5K added.
- The largest ENVUE MEDICAL INC NEW seller in Q1 2026 was Citadel Advisors, an estimated $38.2K sold.
Based on aggregated 13F filings for Q1 2026.